Saratoga Research & Investment Management decreased its holdings in Biogen Inc. (NASDAQ:BIIB – Free Report) by 6.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 164,226 shares of the biotechnology company’s stock after selling 11,838 shares during the period. […]